Literature DB >> 28496767

Atrial Fibrillation and the Role of LAA in Pathophysiology and Clinical Outcomes?

Serkan Saygi1.   

Abstract

Left atrial appendage (LAA) is a source of thromboembolism especially in patients with non valvular atrial fibrillation (AF). It is reasonable to accept LAA as a distinct part of left atrium (LA) with unique anatomical and physiological properties. Advances in imaging modalities increased the knowledge about anatomical and physiological characteristics of LAA. It is important to prevent the AF patients from systemic thromboembolic events, and new pharmacological and non pharmacological management approaches demonstrate encouraging results. Also pulmonary vein isolation which has been accepted as a curative and useful treatment option for the treatment of drug resistant AF has been helpful in understanding the electrophysiological properties of LAA. Accumulating data revealed that LAA continues to be the one of the most important structure of heart during AF because of its distinctive anatomical, mechanical, and electrophysiological properties.

Entities:  

Year:  2012        PMID: 28496767      PMCID: PMC5153207          DOI: 10.4022/jafib.480

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  49 in total

1.  Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination.

Authors:  Michel Haïssaguerre; Prashanthan Sanders; Mélèze Hocini; Yoshihide Takahashi; Martin Rotter; Frederic Sacher; Thomas Rostock; Li-Fern Hsu; Pierre Bordachar; Sylvain Reuter; Raymond Roudaut; Jacques Clémenty; Pierre Jaïs
Journal:  J Cardiovasc Electrophysiol       Date:  2005-11

2.  Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias.

Authors:  Michel Haïssaguerre; Mélèze Hocini; Prashanthan Sanders; Frederic Sacher; Martin Rotter; Yoshihide Takahashi; Thomas Rostock; Li-Fern Hsu; Pierre Bordachar; Sylvain Reuter; Raymond Roudaut; Jacques Clémenty; Pierre Jaïs
Journal:  J Cardiovasc Electrophysiol       Date:  2005-11

3.  Risk of stroke in non-rheumatic atrial fibrillation.

Authors:  K M Flegel; M J Shipley; G Rose
Journal:  Lancet       Date:  1987-03-07       Impact factor: 79.321

4.  Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm.

Authors:  E P Shapiro; M B Effron; S Lima; P Ouyang; C O Siu; D Bush
Journal:  Am J Cardiol       Date:  1988-12-01       Impact factor: 2.778

5.  Assessment of left atrial appendage function by transesophageal echocardiography. Implications for the development of thrombus.

Authors:  C Pollick; D Taylor
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

6.  Left atrial appendage: an underrecognized trigger site of atrial fibrillation.

Authors:  Luigi Di Biase; J David Burkhardt; Prasant Mohanty; Javier Sanchez; Sanghamitra Mohanty; Rodney Horton; G Joseph Gallinghouse; Shane M Bailey; Jason D Zagrodzky; Pasquale Santangeli; Steven Hao; Richard Hongo; Salwa Beheiry; Sakis Themistoclakis; Aldo Bonso; Antonio Rossillo; Andrea Corrado; Antonio Raviele; Amin Al-Ahmad; Paul Wang; Jennifer E Cummings; Robert A Schweikert; Gemma Pelargonio; Antonio Dello Russo; Michela Casella; Pietro Santarelli; William R Lewis; Andrea Natale
Journal:  Circulation       Date:  2010-07-06       Impact factor: 29.690

7.  Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography.

Authors: 
Journal:  Ann Intern Med       Date:  1998-04-15       Impact factor: 25.391

8.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

9.  Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.

Authors:  Peter C Block; Steven Burstein; Paul N Casale; Paul H Kramer; Paul Teirstein; David O Williams; Mark Reisman
Journal:  JACC Cardiovasc Interv       Date:  2009-07       Impact factor: 11.195

10.  Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: identification of a subgroup of patients at increased embolic risk.

Authors:  A Mügge; H Kühn; P Nikutta; J Grote; J A Lopez; W G Daniel
Journal:  J Am Coll Cardiol       Date:  1994-03-01       Impact factor: 24.094

View more
  2 in total

1.  Gross anatomic relationship between the human left atrial appendage and the left ventricular summit region: implications for catheter ablation of ventricular arrhythmias originating from the left ventricular summit.

Authors:  M Kuniewicz; K Budnicka; M Dusza; N Jakob; N Cholewa; R Defonseka; M Gosnell; T Wadhwa; J Walocha; H Dobrzynski; M Hołda
Journal:  J Interv Card Electrophysiol       Date:  2022-03-09       Impact factor: 1.900

2.  Probe Contact Force Monitoring during Conductivity Measurements of the Left Atrial Appendage to Support the Design of Novel Diagnostic and Therapeutic Procedures.

Authors:  Hamza Benchakroun; Niko Ištuk; Eoghan Dunne; Muhammad Adnan Elahi; Tony O'Halloran; Martin O'Halloran; Declan O'Loughlin
Journal:  Sensors (Basel)       Date:  2022-09-21       Impact factor: 3.847

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.